SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-004167
Filing Date
2023-02-21
Accepted
2023-02-21 09:25:07
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20221231.htm   iXBRL 10-K 2159491
2 EX-10.24 a1028ripaamendment3.htm EX-10.24 46952
3 EX-23.1 ex-231q42022.htm EX-23.1 11431
4 EX-31.1 ex-311q42022.htm EX-31.1 10023
5 EX-31.2 ex-312q42022.htm EX-31.2 10264
6 EX-32.1 ex-321q42022.htm EX-32.1 6307
12 espr-20221231_g1.jpg GRAPHIC 76389
  Complete submission text file 0001628280-23-004167.txt   9298046

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20221231.xsd EX-101.SCH 69329
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20221231_cal.xml EX-101.CAL 73392
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20221231_def.xml EX-101.DEF 316531
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20221231_lab.xml EX-101.LAB 829814
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20221231_pre.xml EX-101.PRE 522995
82 EXTRACTED XBRL INSTANCE DOCUMENT espr-20221231_htm.xml XML 1256456
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 23645653
SIC: 2834 Pharmaceutical Preparations